Labcorp Holdings Inc (LH) USD0.10

Sell:$243.38Buy:$254.00$0.22 (0.09%)

Prices delayed by at least 15 minutes
Sell:$243.38
Buy:$254.00
Change:$0.22 (0.09%)
Prices delayed by at least 15 minutes
Sell:$243.38
Buy:$254.00
Change:$0.22 (0.09%)
Prices delayed by at least 15 minutes

Company Information

About this company

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.

Key people

Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Glenn Andrew Eisenberg
Chief Financial Officer, Executive Vice President
Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Anita Z. Graham
Chief Human Resource Officer, Executive Vice President
Lance V. Berberian
Executive Vice President, Chief Information and Technology Officer
Amy B. Summy
Executive Vice President, Chief Marketing Officer
Brian J. Caveney
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Megan D. Bailey
Executive Vice President, Chief Strategy and Transformation Officer
Jonathan P. Divincenzo
Executive Vice President, President, Central Laboratories and International
Garheng Kong
Lead Independent Director
Kerrii B. Anderson
Independent Director
Jeffrey A. Davis
Independent Director
D. Gary Gilliland
Independent Director
Kirsten M. Kliphouse
Independent Director
Click to see more

Key facts

  • EPIC
    LH
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US5049221055
  • Market cap
    $21.50bn
  • Employees
    70,000
  • Shares in issue
    83.70m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.